Monday Mornings Just Got Interesting
August 30, 2026 Bonus Content: At 10x Earnings, Is LULU Cheap or Broken? Sponsored You won’t believe what I’ve been…
Frontline’s $2.61 Dividend Is Earning Its Keep. The Question Is What Happens Next.
With a key VLCC route near WS570 and one-year charters locked at $120,000, the real debate is how Hormuz diplomacy reshapes the payout.
Bill Gates’ AI power prize
August 30, 2026 Bonus Content: HP at $29.62: Value Trap or Cheap Cash Machine? Sponsored Editor’s Note: When the 2008…
How Allocators Are Pricing the AI Buildout
Phase 2 of the chip tariff could turn server OEM bills of materials into a trade-policy variable, and the data center carve-out is the only number that matters.
MRNA Tripled. Now It Has a $2.6B Offering.
Moderna’s Phase 3 melanoma win was historic. Days later, a convertible note deal is the real question investors must answer.
America’s Forgotten Energy Reserve
August 29, 2026 Bonus Content: Gilead’s Bixlenvo Is Approved. Now the Switch Math Begins. Sponsored Dear Reader, On a single…
ROIV Has Its First Approval. Now Comes the Harder Part.
Lisraya wins dermatomyositis, but a boxed warning, a larger patient pool than advertised, and Phase 3 readouts define what the stock is actually worth.
In at 9:35 AM. Out by 10.
August 29, 2026 Bonus Content: The IPO Window Is Open. Now the Fed May Slam It. Sponsored Hey, I’m going…
Make this ONE move to target beating rising costs
August 28, 2026 Bonus Content: 90 Billion Barrels. Now Comes the Hard Part. Sponsored Hi, I’m Alex Reid. I’m a…
When the Architect Wins in Space, Too
What Nvidia’s Starmind bet reveals about durable advantages and founders who compress time.